The Role of Volumetric Neuroimaging in the Evaluation of PTSD

Automated volumetric MR imaging provides an opportunity to utilize brain structure volume measurements to assess symptoms of post-traumatic stress disorder (PTSD) in patients by analyzing the volumes of affected brain regions correlated with PTSD, tracking and evaluating them over time. PTSD can develop in people experiencing or witnessing a life-threatening event, like combat, a natural disaster, a car accident, or sexual assault.

PTSD researchers are currently focusing on volume loss in the amygdala, the ventromedial prefrontal cortex and the hippocampus, which may be affected in response to trauma and chronic stress. The Triage Brain Atrophy report provides the left, right and total normative percentile for the amygdalae, hippocampi and the medial orbitofrontal (considered anatomically synonymous with the ventromedial prefrontal cortex), as well as an overview of 41 additional structures/regions, including the whole brain volume.

Cortechs.ai | The Role of Volumetric Neuroimaging in the Evaluation of PTSD Cortechs.ai | The Role of Volumetric Neuroimaging in the Evaluation of PTSD

For clinicians with a focus on assessing PTSD patients, the Custom Volumetric report can provide brain structure volume measurements for the amygdala, the ventromedial medial prefrontal cortex and the hippocampus. These structures can be divided by right, left, total and the asymmetry between the right and left hemispheres. The resulting volumes are compared to a healthy population via Cortechs.ai’ normative reference data. This allows NeuroQuant to deliver a precise indication of where that individual’s brain structure volumes lie within an age- and gender-based reference chart.

Since PTSD can happen at any age, NeuroQuant reports are applicable for ages 3 to 100 years. Additionally, the clinician is able to review axial, coronal and sagittal DICOM images in which the segmented brain are given a color overlay.

The NeuroQuant Custom Volumetric report provides a multi time point feature, which can be used to assess volume changes in these brain structures by displaying the current measurement together with all previous measurements on the normative reference charts. Physicians can use this information to quickly and easily evaluate longitudinal change in several cortical and subcortical structures.

 

Lopez, Katherine C. et al. (2017) “Brain Volume, Connectivity, and Neuropsychological Performance in Mild Traumatic Brain Injury: The Impact of Post-Traumatic Stress Disorder Symptoms.” Journal of Neurotrauma 34.1: 16–22.

Morey RA, Gold AL, LaBar KS, et al. (2012) Amygdala Volume Changes in Posttraumatic Stress Disorder in a Large Case-Controlled Veterans Group. Arch Gen Psychiatry. 69(11):1169–1178.

More Resources

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network

07/08/2026

The Hidden Tax on Every Head CT You Read

Why automated, consistent alignment, and the reformats it makes possible, may be the most overlooked upgrade in neuroimaging.

06/23/2026

Helping Our Clients Share Their Success Stories

Learn how Cortechs helps clients share clinical achievements, workflow improvements, and innovation through case studies, testimonials, webinars, and more.

06/15/2026

Alzheimer’s Awareness Month: Bringing Clarity to the Alzheimer’s Care Continuum Through Quantitative Imaging

Explore how quantitative imaging is helping clinicians assess, diagnose, and monitor Alzheimer’s disease and related dementias with greater clarity.

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.
Scroll to Top